Cartesian Therapeutics CVR
13F holders, Q3 2025 (September 30)3holders +1
1new positions
0sold out
$0.03avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Cartesian Therapeutics CVR in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Sterling Capital Management LLC ($6K), Ironwood Investment Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 237 shares bought, net +237 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Sterling Capital Management LLC | 0.00% | No change | 8,268 | $6K |
| Ironwood Investment Management LLC | 0.00% | No change | 170,087 | $0 |
| GAMMA Investing LLC | 0.00% | New | 237 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.